SANA
Sana Biotechnology, Inc.
A developer of engineered cell therapies, Sana Biotechnology works to repair or replace damaged cells in the body using its "hypoimmune" technology, which masks cells so a patient's immune system won't reject them. Founded in 2018 by former leaders of the CAR T-cell pioneer Juno Therapeutics, the company takes its name from the Latin word "sana," meaning healthy or sound. Its lead programs are off-the-shelf CAR T-cell therapies in development for autoimmune diseases like lupus.
CUSIP: 799566104HealthcareUS1 holder
Total Value
$2.39M
Total Shares
685.1K
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
